Application 020725

Type
BLA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CREONPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)CAPSULE, DELAYED RELEASE;ORAL30,000USP UNITS;6,000USP UNITS;19,000USP UNITSNoNo
002CREONPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)CAPSULE, DELAYED RELEASE;ORAL60,000USP UNITS;12,000USP UNITS;38,000USP UNITSNoNo
003CREONPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)CAPSULE, DELAYED RELEASE;ORAL120,000USP UNITS;24,000USP UNITS;76,000USP UNITSNoNo
004CREONPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)CAPSULE, DELAYED RELEASE;ORAL15,000USP UNITS;3,000USP UNITS;9,500USP UNITSNoNo
005CREONPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)CAPSULE, DELAYED RELEASE;ORAL180,000USP UNITS;36,000USP UNITS;114,000USP UNITSNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0032-1203CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1203CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1203CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1203CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1203CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1203CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1206CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1206CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1206CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1206CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1206CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1206CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1212CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1212CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1212CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1212CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1212CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1212CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1224CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1224CreonPancrelipaseAbbVie Inc.NDACurrent
0032-1224CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1224CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1224CreonPancrelipaseAbbVie Inc.BLACurrent
0032-1224CreonPancrelipaseAbbVie Inc.BLACurrent
0032-3016CreonPancrelipaseAbbVie Inc.NDACurrent
0032-3016CreonPancrelipaseAbbVie Inc.NDACurrent
0032-3016CreonPancrelipaseAbbVie Inc.BLACurrent
0032-3016CreonPancrelipaseAbbVie Inc.BLACurrent
0032-3016CreonPancrelipaseAbbVie Inc.BLACurrent
0032-3016CreonPancrelipaseAbbVie Inc.BLACurrent
17856-1206CreonPancrelipaseAtlantic Biologicals CorpsNDACurrent
17856-1212CreonPancrelipaseAtlantic Biologicals CorpsNDACurrent
17856-1224CreonPancrelipaseAtlantic Biologicals CorpsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77663SUPPL 2024-02-29
77662SUPPL 2024-02-29
77653SUPPL 2024-02-29
71249SUPPL2022-06-07
71248SUPPL2022-06-07
71208SUPPL2022-06-03
66389APPL2020-03-23
62261SUPPL2020-03-23
62255SUPPL2020-03-23
62254SUPPL2020-03-23
62232SUPPL2020-03-23
58661SUPPL2020-03-23
51453SUPPL2020-03-23
46120SUPPL2020-03-23
41622ORIG2020-03-23
35237SUPPL2020-03-23
35236SUPPL2020-03-23
35235SUPPL2020-03-23
35234ORIG2020-03-23
25637SUPPL2020-03-23
24180ORIG2020-03-23
13293SUPPL2020-03-23
13292SUPPL2020-03-23
13291SUPPL2020-03-23
13290SUPPL2020-03-23
3211SUPPL2020-03-23
3210SUPPL2020-03-23
3209SUPPL2020-03-23
3208SUPPL2020-03-23
3207SUPPL2020-03-23
3206ORIG2020-03-23
67139SUPPL1900-01-01
63534ORIG1900-01-01
63533ORIG1900-01-01
63229ORIG1900-01-01